“Stibogluconate, which is used to treat cutaneous leishmaniasis of the new world, is not an arsenic based compound, as stated in the text accompanying the Minerva picture on p 1122 in the issue of 9 November; it is an antimony based compound.”
“Stibogluconate, which is used to treat cutaneous leishmaniasis of the new world, is not an arsenic based compound, as stated in the text accompanying the Minerva picture on p 1122 in the issue of 9 November; it is an antimony based compound.”